Suppression of oncoprotein her-2 and DNA damage after treatment with flavan-3-ol vitis labrusca extract

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 7, 2013, Pages 1088-1095

  Scola, Gustavo ^a   Laurino, Claudia Cilene Fernandes Correia ^a,b   Menin, Eveline ^a   Salvadora, Mirian ^a  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anti proliferative; Apoptosis; Breast cancer; Flavan 3 ol; Liver cancer

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CATECHIN; EPICATECHIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIGALLOCATECHIN; FLAVAN 3 OL; HERBACEOUS AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROCYANIDIN; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; GENE REPRESSION; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; SCORING SYSTEM; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; DNA DAMAGE; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MCF-7 CELLS; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53; VITIS;

EID: 84882738579     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113139990135     Document Type: Article

References (46)

1. Raskin, I.; Ribnicky, D. M.; Komarnytsky, S.; Ilic, N.; Poulev, A.; Borisjuk, N.; Brinker, A.; Moreno, D. A.; Ripoll, C.; Yakoby, N.; O'Neal, J. M.; Cornwell, T.; Pastor, I.; Fridlender, B. Plants and human health in the twenty-first century. Trends Biotechnol., 2002, 20(12), 522-31.
2. Winkler, A. J.; Cook, J. A.; Kliewer, W. M.; Lider, L. A. General viticulture, 1st ed.; University of California Press: Los Angeles, 1997.
3. Scola, G.; Conte, D.; Spada, P. W. D.-S.; Dani, C.; Vanderlinde, R.; Funchal, C.; Salvador, M. Flavan-3-ol Compounds from Wine Wastes with in vitro and in vivo Antioxidant Activity. Nutrients, 2010, 2(10), 1048-1059.
4. Scola, G.; Kappel, V. D.; Moreira, J. C. F.; Dal-Pizzol, F.; Salvador, M. Antioxidant and anti-inflammatory activities of winery wastes seeds of Vitis labrusca. Ciência Rural, 2011, 41(7), 1233-1238.
5. Roy, A. M.; Baliga, M. S.; Elmets, C. A.; Katiyar, S. K. Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways. Neoplasia, 2005, 7(1), 24-36.
6. Shi, J.; Yu, J.; Pohorly, J. E.; Kakuda, Y. Polyphenolics in grape seedsbiochemistry and functionality. J. Med. Food., 2003, 6(4), 291-9.
7. Sangeetha, P.; Balu, M.; Haripriya, D.; Panneerselvam, C. Age associated changes in erythrocyte membrane surface charge: Modulatory role of grape seed proanthocyanidins. Exp. Gerontol., 2005, 40(10), 820-8.
8. Crozier, A.; Jaganath, I. B.; Clifford, M. N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep., 2009, 26(8), 1001-43.
9. Babich, H.; Krupka, M. E.; Nissim, H. A.; Zuckerbraun, H. L. Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity. Toxicol. In Vitro, 2005, 19(2), 231-42
10. Ye, X.; Krohn, R. L.; Liu, W.; Joshi, S. S.; Kuszynski, C. A.; McGinn, T. R.; Bagchi, M.; Preuss, H. G.; Stohs, S. J.; Bagchi, D. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol. Cell. Biochem., 1999, 196(1-2), 99-108.
11. World Health Organization. Health topics: Breast cancer. http://www.who.int/cancer/detection/breastcancer/en/index1.html (Accessed May 10, 2012).
12. World Health Organization. Health topics: World Cancer Day 2012. http://www.who.int/cancer/events/world_cancerday2012/en/ (Accessed May 10, 2012).
13. Boyle, P.; Howell, A. The globalisation of breast cancer. Breast Cancer Res., 2010, 12 Suppl 4, S7.
14. Song, J. M.; Lu, M.; Liu, F. F.; Du, X. J.; Xing, B. C. AIB1 as an Independent Prognostic Marker in Hepatocellular Carcinoma After Hepatic Resection. J. Gastrointest. Surg. 2012, 16(2):356-60.
15. Ray, R. B.; Raychoudhuri, A.; Steele, R.; Nerurkar, P. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res., 2010, 70(5), 1925-31.
16. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 1987, 47(4), 936-42.
17. Green, L. C.; Tannenbaum, S. R.; Goldman, P. Nitrate synthesis in the germfree and conventional rat. Science, 1981, 212(4490), 56-8.
18. Collins, A. R.; Oscoz, A. A.; Brunborg, G.; Gaivao, I.; Giovannelli, L.; Kruszewski, M.; Smith, C. C.; Stetina, R. The comet assay: topical issues. Mutagenesis 2008, 23(3), 143-51.
19. Nandakumar, V.; Singh, T.; Katiyar, S. K. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett., 2008, 269(2), 378-87.
20. Mittal, A.; Elmets, C. A.; Katiyar, S. K. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis, 2003, 24(8), 1379-88.
21. Bagchi, D.; Bagchi, M.; Stohs, S. J.; Das, D. K.; Ray, S. D.; Kuszynski, C. A.; Joshi, S. S.; Pruess, H. G. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology,2000, 148(2-3), 187-97.
22. Raina, K.; Singh, R. P.; Agarwal, R.; Agarwal, C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res., 2007, 67(12), 5976-82
23. Kijima, I.; Phung, S.; Hur, G.; Kwok, S. L.; Chen, S. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res., 2006, 66(11), 5960-7.
24. Dinicola, S.; Cucina, A.; Pasqualato, A.; Proietti, S.; D'Anselmi, F.; Pasqua, G.; Santamaria, A. R.; Coluccia, P.; Lagana, A.; Antonacci, D.; Giuliani, A.; Bizzarri, M. Apoptosis-inducing factor and caspase-dependent apoptotic pathways triggered by different grape seed extracts on human colon cancer cell line Caco-2. Br. J. Nutr., 2010, 104(6), 824-32.
25. Mantena, S. K.; Baliga, M. S.; Katiyar, S. K. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis, 2006, 27(8), 1682-91.
26. Saeki, K.; Hayakawa, S.; Isemura, M.; Miyase, T. Importance of a pyrogallol-type structure in catechin compounds for apoptosisinducing activity. Phytochemistry, 2000, 53(3), 391-4.
27. Inaba, H.; Nagaoka, Y.; Kushima, Y.; Kumagai, A.; Matsumoto, Y.; Sakaguchi, M.; Baba, K.; Uesato, S. Comparative examination of anti-proliferative activities of (-)-epigallocatechin gallate and (-)-epigallocatechin against HCT116 colorectal carcinoma cells. Biol. Pharm. Bull., 2008, 31(1), 79-84.
28. Denmeade, S. R.; Isaacs, J. T. Programmed Cell Death (Apoptosis) and Cancer Chemotherapy. Cancer Control, 1996, 3(4), 303-309.
29. Shamim, U.; Hanif, S.; Albanyan, A.; Beck, F. W.; Bao, B.; Wang, Z.; Banerjee, S.; Sarkar, F. H.; Mohammad, R. M.; Hadi, S. M.; Azmi, A. S. Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer. J. Cell. Physiol., 2011, 227(4):1493-500
30. Hadi, S. M.; Asad, S. F.; Singh, S.; Ahmad, A. Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life, 2000, 50(3), 167-71.
31. Tretyakova, N. Y.; Burney, S.; Pamir, B.; Wishnok, J. S.; Dedon, P. C.; Wogan, G. N.; Tannenbaum, S. R. Peroxynitrite-induced DNA damage in the supF gene: correlation with the mutational spectrum. Mutat. Res., 2000, 447(2), 287-303.
32. Ambs, S.; Ogunfusika, M. O.; Merriam, W. G.; Bennett, W. P.; Billiar, T. R.; Harris, C. C. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc. Natl. Acad. Sci. U. S. A., 1998, 95(15), 8823-8.
33. el Ghissassi, F.; Barbin, A.; Nair, J.; Bartsch, H. Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem. Res.Toxicol., 1995, 8(2), 278-83.
34. Ghosh, J. C.; Dohi, T.; Raskett, C. M.; Kowalik, T. F.; Altieri, D. C. Activated checkpoint kinase 2 provides a survival signal for tumor cells. Cancer Res., 2006, 66(24), 11576-9.
35. Marzo, I.; Brenner, C.; Zamzami, N.; Jurgensmeier, J. M.; Susin, S. A.; Vieira, H. L.; Prevost, M. C.; Xie, Z.; Matsuyama, S.; Reed, J. C.; Kroemer, G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science, 1998, 281(5385), 2027-31.
36. Green, D. R.; Reed, J. C. Mitochondria and apoptosis. Science, 1998, 281(5381), 1309-12.
37. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; Larochette, N.; Goodlett, D. R.; Aebersold, R.; Siderovski, D. P.; Penninger, J. M.; Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 1999, 397(6718), 441-6.
38. Bidere, N.; Lorenzo, H. K.; Carmona, S.; Laforge, M.; Harper, F.; Dumont, C.; Senik, A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem., 2003, 278(33), 31401-11.
39. Engelbrecht, A. M.; Mattheyse, M.; Ellis, B.; Loos, B.; Thomas, M.; Smith, R.; Peters, S.; Smith, C.; Myburgh, K. Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line. Cancer Lett., 2007, 258(1), 144-53.
40. Chen, A. PARP inhibitors: its role in treatment of cancer. Chin. J. Cancer, 2011, 30(7), 463-71.
41. Wahlberg, E.; Karlberg, T.; Kouznetsova, E.; Markova, N.; Macchiarulo, A.; Thorsell, A. G.; Pol, E.; Frostell, A.; Ekblad, T.; Oncu, D.; Kull, B.; Robertson, G. M.; Pellicciari, R.; Schuler, H.; Weigelt, J. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat. Biotechnol., 2012, 30(3), 283-8.
42. Bartsch, R.; Wenzel, C.; Zielinski, C. C.; Steger, G. G. HER-2-positive breast cancer: hope beyond trastuzumab. BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2007, 21(2), 69-77.
43. Menendez, J. A.; Vazquez-Martin, A.; Garcia-Villalba, R.; Carrasco-Pancorbo, A.; Oliveras-Ferraros, C.; Fernandez-Gutierrez, A.; Segura-Carretero, A. tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). BMC Cancer, 2008, 8, 377.
44. Owens, M. A.; Horten, B. C.; Da Silva, M. M. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clinical breast cancer, 2004, 5(1), 63-9.
45. Xian, Z. H.; Zhang, S. H.; Cong, W. M.; Wu, W. Q.; Wu, M. C. Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma. J. Clin. Pathol., 2005, 58(5), 500-3.
46. Musolino, A.; Naldi, N.; Bortesi, B.; Pezzuolo, D.; Capelletti, M.; Missale, G.; Laccabue, D.; Zerbini, A.; Camisa, R.; Bisagni, G.; Neri, T. M.; Ardizzoni, A. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J. Clin. Oncol., 2008, 26(11), 1789-96.